Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 16 (RPL12P16)

Target
RPL12P16
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L12 pseudogene 16 (RPL12P16) is a processed pseudogene, meaning it is a non-functional copy of the ribosomal protein L12 (RPL12) gene, present within the human genome[5][8]. Pseudogenes like RPL12P16 are typically transcribed fragments or copies of protein-coding genes that have acquired mutations preventing them from producing functional proteins[10]. The parental gene RPL12 encodes a component of the 60S large subunit of the ribosome, which is essential for protein synthesis, but the RPL12P16 pseudogene itself does not have a known protein product or biological function and is not regarded as a receptor, enzyme, transporter, or therapeutic target[3][5][8][10]. Current data do not associate RPL12P16 with any drug interactions, disease pathogenesis, or clinical biomarker use[5][10]. RPL12P16 is listed as a distinct genomic locus and has an official symbol, according to the HUGO Gene Nomenclature Committee[8]. There is no evidence this pseudogene produces a functional protein, nor is it currently considered druggable or directly actionable in disease[5][10]. Like many ribosomal protein pseudogenes, RPL12P16 may be transcribed, but its transcripts are not known to be translated or confer function[10].

Other names
RPL12P16ribosomal protein L12 pseudogene 16
02

Biological functions

Other (no direct function; pseudogene)
03

Disease associations

Other (no direct implication as a causative gene or biomarker for major diseases as of current knowledge)

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 16 (RPL12P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 16 (RPL12P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call